Accessing biological actions of Ganoderma secondary metabolites by in silico profiling

Phytochemistry

Volumn 114, Issue , 2015, Pages 114-124

  Grienke, Ulrike ^a   Kaserer, Teresa ^a   Pfluger, Florian ^a   Mair, Christina E ^a   Langer, Thierry ^b   Schuster, Daniela ^a   Rollinger, Judith M ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antiviral targets; Ganoderma lucidum; Ganodermataceae; Metabolic syndrome; Pharmacophore profiling; Triterpenes; Virtual screening

Indexed keywords

FUNGI; GANODERMA; GANODERMA LUCIDUM; GANODERMATACEAE;

ANTIVIRUS AGENT; HERBACEOUS AGENT; POLYSACCHARIDE; TRITERPENE;

CHEMICAL STRUCTURE; CHEMISTRY; GANODERMA LUCIDUM; ISOLATION AND PURIFICATION;

ANTIVIRAL AGENTS; DRUGS, CHINESE HERBAL; MOLECULAR STRUCTURE; POLYSACCHARIDES; REISHI; TRITERPENES;

EID: 84929705249     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2014.10.010     Document Type: Article

References (94)

1. Accelrys Software Inc. Pipeline Pilot, Release 8.5 2011 Accelrys Software Inc. San Diego
2. Accelrys Software Inc. Discovery Studio Modeling Environment, Release 3.5 2012 Accelrys Software Inc. San Diego
3. A. Alexopoulou, and G.V. Papatheodoridis Current progress in the treatment of chronic hepatitis C World J. Gastroenterol. 18 2012 6060 6069
4. E.J. Arts, and D.J. Hazuda HIV-1 antiretroviral drug therapy Cold Spring Harb. Perspect. Med. 2 2012 a007161
5. L. Barros, T. Cruz, P. Baptista, L.M. Estevinho, and I.C. Ferreira Wild and commercial mushrooms as source of nutrients and nutraceuticals Food Chem. Toxicol. 46 2008 2742 2747
6. M.S. Bastami, S.P.M. Bohari, W.M. Har, M.N. Wahab, A.S. Rahmani, N.F. Rajab, and M. Hamid Hypoglycemic, insulinotropic and cytotoxic activity of three species of Ganoderma Malays. J. Sci. 26 2007 41 46
7. A. Berger, D. Rein, E. Kratky, I. Monnard, H. Hajjaj, I. Meirim, C. Piguet-Welsch, J. Hauser, K. Mace, and P. Niederberger Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs Lipids Health Dis. 3 2004 2
8. G. Bryzgalova, S. Effendic, A. Khan, S. Rehnmark, P. Barbounis, J. Boulet, G. Dong, R. Singh, S. Shapses, J. Malm, P. Webb, J.D. Baxter, and G.J. Grover Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141 J. Steroid Biochem. Mol. Biol. 111 2008 262 267
9. M.J. Chapman, W. Le Goff, M. Guerin, and A. Kontush Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors Eur. Heart J. 31 2010 149 164
10. S. D'Amore, M. Vacca, G. Graziano, A. D'Orazio, M. Cariello, N. Martelli, G. Di Tullio, R. Salvia, G. Grandaliano, A. Belfiore, F. Pellegrini, G. Palasciano, and A. Moschetta Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with metabolic syndrome Biochim. Biophys. Acta 1832 2013 2289 2301
11. K. Duwensee, S. Schwaiger, I. Tancevski, K. Eller, M. van Eck, P. Markt, T. Linder, U. Stanzl, A. Ritsch, J.R. Patsch, D. Schuster, H. Stuppner, D. Bernhard, and P. Eller Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein Atherosclerosis 219 2011 109 115
12. R.S. El Dine, A.M. El Halawany, C.-M. Ma, and M. Hattori Anti-HIV-1 protease activity of lanostane triterpenes from the Vietnamese mushroom Ganoderma colossum J. Nat. Prod. 71 2008 1022 1026
13. R.S. El Dine, A.M. El Halawany, C.-M. Ma, and M. Hattori Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum J. Nat. Prod. 72 2009 2019 2023
14. S. El-Mekkawy, M.R. Meselhy, N. Nakamura, Y. Tezuka, M. Hattori, N. Kakiuchi, K. Shimotohno, T. Kawahata, and T. Otake Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum Phytochemistry 49 1998 1651 1657
15. S.K. Eo, Y.S. Kim, C.K. Lee, and S.S. Han Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum J. Ethnopharmacol. 68 1999 129 136
16. N. Fakhrudin, A. Ladurner, A.G. Atanasov, E.H. Heiss, L. Baumgartner, P. Markt, D. Schuster, E.P. Ellmerer, G. Wolber, J.M. Rollinger, H. Stuppner, and V.M. Dirsch Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma Mol. Pharmacol. 77 2010 559 566
17. S. Fatmawati, K. Kurashiki, S. Takeno, Y.U. Kim, K. Shimizu, M. Sato, K. Imaizumi, K. Takahashi, S. Kamiya, S. Kaneko, and R. Kondo The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum Phytother. Res. 23 2009 28 32
18. S. Fatmawati, K. Shimizu, and R. Kondo Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum Fitoterapia 81 2010 1033 1036
19. S. Fatmawati, K. Shimizu, and R. Kondo Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum Planta Med. 76 2010 1691 1693
20. S. Fatmawati, K. Shimizu, and R. Kondo Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors Bioorg. Med. Chem. Lett. 21 2011 7295 7297
21. M. Feher, and J.M. Schmidt Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry J. Chem. Inf. Model. 43 2003 218 227
22. L.L. Gathercole, G.G. Lavery, S.A. Morgan, M.S. Cooper, A.J. Sinclair, J.W. Tomlinson, and P.M. Stewart 11beta-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects Endocr. Rev. 34 2013 525 555
23. R.K. Goel, D. Singh, A. Lagunin, and V. Poroikov PASS-assisted exploration of new therapeutic potential of natural products Med. Chem. Res. 20 2011 1509 1514
24. A.C. Goldberg Emerging low-density lipoprotein therapies: microsomal triglyceride transfer protein inhibitors J. Clin. Lipidol. 7 2013 16 20
25. U. Grienke, J. Mihaly-Bison, D. Schuster, T. Afonyushkin, M. Binder, S.H. Guan, C.R. Cheng, G. Wolber, H. Stuppner, D.A. Guo, V.N. Bochkov, and J.M. Rollinger Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum Bioorg. Med. Chem. 19 2011 6779 6791
26. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., C. Lenfant, A. American Heart, L. National Heart, and I. Blood Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
27. P.C. Hawkins, and A. Nicholls Conformer generation with OMEGA: learning from the data set and the analysis of failures J. Chem. Inf. Model. 52 2012 2919 2936
28. P.C.D. Hawkins, A.G. Skillman, G.L. Warren, B.A. Ellingson, and M.T. Stahl Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database J. Chem. Inf. Model. 50 2010 572 584
29. S.-P. Huang, G.-J. Shieh, J.-L. Ko, Z.-Y. Weng, J.-G. Lin, and J.-C. Chen Inhibition of subgenomic hepatitis C virus RNA transcription by Chinese herbal extracts Pharm. Biol. 47 2009 111 119
30. Z. Huang, F. Fang, and C.-W. Wong Ganoderma lucidum spore lipid induces peroxisome proliferator-activated receptor alpha activity J. Food Biochem. 35 2011 1508 1513
31. T.O. Johnson, J. Ermolieff, and M.R. Jirousek Protein tyrosine phosphatase 1B inhibitors for diabetes Nat. Rev. Drug Discov. 1 2002 696 709
32. S.H. Jung, Y.S. Lee, S.H. Shim, S. Lee, K.H. Shin, J.S. Kim, Y.S. Kim, and S.S. Kang Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues Phytother. Res. 19 2005 477 480
33. Y. Kabir, S. Kimura, and T. Tamura Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR) J. Nutr. Sci. Vitaminol. 34 1988 433 438
34. Y. Kagaya, S. Hatakeyama, T. Goto, N. Miura, N. Tsujimura, and K. Sakamoto Studies on Ganoderma lucidum - III the effects of Rokkaku reishi extract on arterial pressure level and serum glucose level Res. Commun. Pharmacol. Toxicol. 6 2001 135 138
35. A. Kamali, and M. Holodniy Influenza treatment and prophylaxis with neuraminidase inhibitors: a review Infect. Drug Resist. 6 2013 187 198
36. K. Kanmatsuse, N. Kajiwara, K. Hayashi, S. Shimogaichi, I. Fukinbara, H. Ishikawa, and T. Tamura Studies on Ganoderma lucidum. I. Efficacy against hypertension and side effects Yakugaku Zasshi 105 1985 942 947
37. H.W. Kim, M.J. Shim, E.C. Choi, and B.K. Kim Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum Arch. Pharm. Res. 20 1997 425 431
38. A. La Cava, and G. Matarese The weight of leptin in immunity Nat. Rev. Immunol. 4 2004 371 379
39. L.K. Lai, N.Z. Abidin, N. Abdullah, and V. Sabaratnam Anti-human papillomavirus (HPV) 16 E6 activity of Ling Zhi or reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) extracts Int. J. Med. Mushrooms 12 2010 279 286
40. J. Larsson, J. Gottfries, L. Bohlin, and A. Backlund Expanding the ChemGPS chemical space with natural products J. Nat. Prod. 68 2005 985 991
41. R.M. Ledford, N.R. Patel, T.M. Demenczuk, A. Watanyar, T. Herbertz, M.S. Collett, and D.C. Pevear VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds J. Virol. 78 2004 3663 3674
42. S.Y. Lee, and H.M. Rhee Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action Chem. Pharm. Bull. 38 1990 1359 1364
43. S.H. Lee, S.H. Shim, J.S. Kim, and S.S. Kang Constituents from the fruiting bodies of Ganoderma applanatum and their aldose reductase inhibitory activity Arch. Pharm. Res. 29 2006 479 483
44. C. Li, Y. Li, and H.H. Sun New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum Nat. Prod. Res. 20 2006 985 991
45. U. Lindequist, R. Rausch, A. Fussel, and H.P. Hanssen Higher fungi in traditional and modern medicine Med. Monatsschr. Pharm. 33 2010 40 48
46. J. Liu, K. Kurashiki, A. Fukuta, S. Kaneko, Y. Suimi, K. Shimizu, and R. Kondo Quantitative determination of the representative triterpenoids in the extracts of Ganoderma lucidum with different growth stages using high-performance liquid chromatography for evaluation of their 5α-reductase inhibitory properties Food Chem. 133 2012 1034 1038
47. P. Markt, D. Schuster, J. Kirchmair, C. Laggner, and T. Langer Pharmacophore modeling and parallel screening for PPAR ligands J. Comput.-Aided Mol. Des. 21 2007 575 590
48. P. Markt, R.K. Petersen, E.N. Flindt, K. Kristiansen, J. Kirchmair, G. Spitzer, S. Distinto, D. Schuster, G. Wolber, C. Laggner, and T. Langer Discovery of novel PPAR Ligands by a virtual screening approach based on pharmacophore modeling, 3D shape, and electrostatic similarity screening J. Med. Chem. 51 2008 6303 6317
49. P. Markt, C. Feldmann, J.M. Rollinger, S. Radurner, D. Schuster, J. Kirchmair, S. Distinto, G.M. Spitzer, G. Wolber, C. Laggner, K.H. Altmann, T. Langer, and J. Gertsch Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow J. Med. Chem. 52 2009 369 378
50. V. Marzolla, A. Armani, M.C. Zennaro, F. Cinti, C. Mammi, A. Fabbri, G.M. Rosano, and M. Caprio The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism Mol. Cell. Endocrinol. 350 2012 281 288
51. B.M. McArdle, and R.J. Quinn Identification of protein fold topology shared between different folds inhibited by natural products ChemBioChem 8 2007 788 798
52. B.S. Min, N. Nakamura, H. Miyashiro, K.W. Bae, and M. Hattori Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease Chem. Pharm. Bull. 46 1998 1607 1612
53. Y. Mizushina, N. Takahashi, L. Hanashima, H. Koshino, Y. Esumi, J. Uzawa, F. Sugawara, and K. Sakaguchi Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum Bioorg. Med. Chem. 7 1999 2047 2052
54. A. Mohammed, A.B. Adelaiye, A.G. Bakari, and M.A. Mabrouk Anti-diabetic and some hematological effects of ethylacetate and n-butanol fractions of Ganoderma lucidum aqueous extract in alloxan - induced diabetic Wister rats Int. J. Med. Med. Sci. 1 2009 530 535
55. R.A. Mothana, N.A. Awadh Ali, R. Jansen, U. Wegner, R. Mentel, and U. Lindequist Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi Fitoterapia 74 2003 177 180
56. H. Nambu, E. Kubo, Y. Takamura, S. Tsuzuki, M. Tamura, and Y. Akagi Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells Diab. Res. Clin. Pract. 82 2008 18 24
57. T.H.J. Niedermeyer, U. Lindequist, R. Mentel, D. Gordes, E. Schmidt, K. Thurow, and M. Lalk Antiviral terpenoid constituents of Ganoderma pfeifferi J. Nat. Prod. 68 2005 1728 1731
58. S.M. Noha, A.G. Atanasov, D. Schuster, P. Markt, N. Fakhrudin, E.H. Heiss, O. Schrammel, J.M. Rollinger, H. Stuppner, V.M. Dirsch, and G. Wolber Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques Bioorg. Med. Chem. Lett. 21 2011 577 583
59. A. Odermatt, and D.V. Kratschmar Tissue-specific modulation of mineralocorticoid receptor function by 11beta-hydroxysteroid dehydrogenases: an overview Mol. Cell. Endocrinol. 350 2012 168 186
60. OMEGA version 2.3.2., 2008. OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
61. D. Pan, L. Wang, B. Hu, and P. Zhou Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes Biopolymers 101 2014 613 623
62. R.R.M. Paterson Ganoderma - a therapeutic fungal biofactory Phytochemistry 67 2006 1985 2001
63. PerkinElmer, 2008. ChemBioDraw Ultra 11.0, Waltham, MA.
64. J.M. Rollinger Accessing target information by virtual parallel screening - the impact on natural product research Phytochem. Lett. 2 2009 53 58
65. J.M. Rollinger, and G. Wolber Computational approaches for the discovery of natural lead structures Bioactive Compounds from Natural Sources 2nd ed. 2011 CRC Press 97 132
66. J.M. Rollinger, D. Schuster, B. Danzl, S. Schwaiger, P. Markt, M. Schmidtke, J. Gertsch, S. Raduner, G. Wolber, T. Langer, and H. Stuppner In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens Planta Med. 75 2009 195 204
67. B.S. Sanodiya, G.S. Thakur, R.K. Baghel, G.B. Prasad, and P.S. Bisen Ganoderma lucidum: a potent pharmacological macrofungus Curr. Pharm. Biotechnol. 10 2009 717 742
68. N. Sato, C.-M. Ma, K. Komatsu, and M. Hattori Triterpene-farnesyl hydroquinone conjugates from Ganoderma sinense J. Nat. Prod. 72 2009 958 961
69. D. Schuster 3D pharmacophores as tools for activity profiling Drug Discovery Today: Technol. 7 2010 205 211
70. D. Schuster, E.M. Maurer, C. Laggner, L.G. Nashev, T. Wilckens, T. Langer, and A. Odermatt The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening J. Med. Chem. 49 2006 3454 3466
71. D. Schuster, M. Spetea, M. Music, S. Rief, M. Fink, J. Kirchmair, J. Schütz, G. Wolber, H. Stuppner, H. Schmidhammer, and J.M. Rollinger Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors Bioorg. Med. Chem. 18 2010 5071 5080
72. D. Schuster, P. Markt, U. Grienke, J. Mihály-Bison, M. Binder, S.M. Noha, J.M. Rollinger, H. Stuppner, V.N. Bochkov, and G. Wolber Pharmacophore-based discovery of FXR agonists. Part I: model development and experimental validation Bioorg. Med. Chem. 19 2011 7168 7180
73. T. Scior, A. Bender, G. Tresadern, J.L. Medina-Franco, K. Martinez-Mayorga, T. Langer, K. Cuanalo-Contreras, and D.K. Agrafiotis Recognizing pitfalls in virtual screening: a critical review J. Chem. Inf. Model. 52 2012 867 881
74. S.A. Scott, T.P. Mathews, P.T. Ivanova, C.W. Lindsley, and H.A. Brown Chemical modulation of glycerolipid signaling and metabolic pathways Biochim. Biophys. Acta 2014 10.1016/j.bbalip.2014.01.009 in print
75. S.W. Seto, T.Y. Lam, H.L. Tam, A.L.S. Au, S.W. Chan, J.H. Wu, P.H.F. Yu, G.P.H. Leung, S.M. Ngai, J.H.K. Yeung, P.S. Leung, S.M.Y. Lee, and Y.W. Kwan Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice Phytomedicine 16 2009 426 436
76. Y. Shimojo, K. Kosaka, and T. Shirasawa Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine pre-adipocyte cell line, 3T3-L1 Phytother. Res. 25 2011 202 207
77. T. Steindl, and T. Langer Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening J. Chem. Inf. Comput. Sci. 44 2004 1849 1856
78. T. Steindl, and T. Langer Docking versus pharmacophore model generation: a comparison of high-throughput virtual screening strategies for the search of human rhinovirus coat protein inhibitors QSAR Comb. Sci. 24 2005 470 479
79. T.M. Steindl, C.E. Crump, F.G. Hayden, and T. Langer Pharmacophore modelling, docking, and principal component analysis-based clustering: combined computer-assisted approaches to identify new inhibitors of the human rhino virus coat protein J. Med. Chem. 48 2005 6250 6260
80. T.M. Steindl, D. Schuster, C. Laggner, and T. Langer Parallel screening: a novel concept in pharmacophore modeling and virtual screening J. Chem. Inf. Model. 46 2006 2146 2157
81. T.M. Steindl, D. Schuster, G. Wolber, C. Laggner, and T. Langer High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening J. Comput.-Aided Mol. Des. 20 2006 703 715
82. G. Szedlay Is the widely used medicinal fungus the Ganoderma lucidum (Fr.) Karst. sensu stricto? Acta Microbiol. Immunol. Hung. 49 2002 235 243
83. W.H. Tang, K.A. Martin, and J. Hwa Aldose reductase, oxidative stress, and diabetic mellitus Front. Pharmacol. 3 2012 87
84. B.S. Teng, C.D. Wang, H.J. Yang, J.S. Wu, D. Zhang, M. Zheng, Z.H. Fan, D. Pan, and P. Zhou A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice J. Agric. Food Chem. 59 2011 6492 6500
85. B.S. Teng, C.D. Wang, D. Zhang, J.S. Wu, D. Pan, L.F. Pan, H.J. Yang, and P. Zhou Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats Eur. Rev. Med. Pharmacol. Sci. 16 2012 166 175
86. A. Thyagarajan-Sahu, B. Lane, and D. Sliva ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK BMC Complement. Altern. Med. 11 2011 74
87. L. Tornatore, A.K. Thotakura, J. Bennett, M. Moretti, and G. Franzoso The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation Trends Cell Biol. 22 2012 557 566
88. S. von Grafenstein, J. Mihály-Bison, G. Wolber, V.N. Bochkov, K.R. Liedl, and D. Schuster Identification of novel liver X receptor activators by structure-based modeling J. Chem. Inf. Model. 52 2012 1391
89. A. Vuorinen, L.G. Nashev, A. Odermatt, J.M. Rollinger, and D. Schuster Pharmacophore model refinement for 11β-hydroxysteroid dehydrogenase inhibitors: search for modulators of intracellular glucocorticoid concentrations Mol. Inf. 33 2014 15 25
90. C.-D. Wang, B.-S. Teng, Y.-M. He, J.-S. Wu, D. Pan, L.-F. Pan, D. Zhang, Z.-H. Fan, H.-J. Yang, and P. Zhou Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice Br. J. Nutr. 108 2012 2014 2025
91. C.-G. Wermuth, C.R. Ganellin, P. Lindberg, and L.A. Mitscher Glossary of terms used in medicinal chemistry (IUPAC recommendations, 1997) Annu. Rep. Med. Chem. 33 1998 385 395
92. G. Wolber, and T. Langer LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 45 2005 160 169
93. Z. Yan, B. Xia, M.H. Qiu, L.S. Ding, and H.X. Xu Fast analysis of triterpenoids in Ganoderma lucidum spores by ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry Biomed. Chromatogr. 27 2013 1560 1567
94. J. Zhao, X.-Q. Zhang, S.-P. Li, F.-Q. Yang, Y.-T. Wang, and W.-C. Ye Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography J. Sep. Sci. 29 2006 2609 2615